SCHEMBL7669252

SCHEMBL7669252

Cc1nc2ccc(C(=O)S(=O)(=O)c3ccc(Br)s3)nc2n1Cc1ccc(CCc2ccccc2)cc1Cl

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
MAPT P10636 2/20 0.36
ALDH1A1 P00352 1/20 0.36
PPARG P37231 8/20 0.35
LMNA P02545 2/20 0.33
HTT P42858 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HDAC9 Q9UKV0 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6134461 0.89 MAPT (0.38) KMT2ASMN1; SMN2MAPTALDH1A1PPARG
SCHEMBL6299082 0.84 KMT2A (0.44) KMT2ASMN1; SMN2MAPTALDH1A1PPARG
SCHEMBL6306004 0.81 PPARG (0.41) KMT2ASMN1; SMN2MAPTALDH1A1PPARG
SCHEMBL6299833 0.81 KMT2A (0.44) KMT2ASMN1; SMN2MAPTALDH1A1PPARG
SCHEMBL6299297 0.80 MAPT (0.36) KMT2ASMN1; SMN2MAPTALDH1A1PPARG
SCHEMBL6299210 0.79 MAPT (0.39) KMT2ASMN1; SMN2MAPTALDH1A1PPARG
SCHEMBL6299858 0.79 CCR2 (0.44) KMT2ASMN1; SMN2MAPTALDH1A1PPARG
SCHEMBL6305630 0.79 S1PR1 (0.39) KMT2ASMN1; SMN2MAPTALDH1A1PPARG
SCHEMBL6300478 0.79 MAPT (0.38) KMT2ASMN1; SMN2MAPTALDH1A1PPARG
SCHEMBL6300476 0.79 MAPT (0.38) KMT2ASMN1; SMN2MAPTALDH1A1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6348474-B1 COMPOUNDS AS ANTIDIABETIC AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed